Generex Biotechnology

NuGenerex is a technology company focused on the development of innovative peptide-based drugs, engaging in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immune diseases. It has developed a proprietary platform technology for the oral administration of macromolecular drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The company's products include Generex Oral-lyn, an insulin spray formulation used to treat type 1 and type 2 diabetes. Additionally, through its subsidiaries, the company develops patented vaccine formulations that work by stimulating the immune system to attack cancer cells, bacteria, and viruses or to stop attacking benign elements.